406 related articles for article (PubMed ID: 36243806)
1. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.
Su GH; Xiao Y; Jiang L; Zheng RC; Wang H; Chen Y; Gu YJ; You C; Shao ZM
J Transl Med; 2022 Oct; 20(1):471. PubMed ID: 36243806
[TBL] [Abstract][Full Text] [Related]
2. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
4. CT-based radiomics signature to predict CD8+ tumor infiltrating lymphocytes in non-small-cell lung cancer.
Chen Y; Xu T; Jiang C; You S; Cheng Z; Gong J
Acta Radiol; 2023 Apr; 64(4):1390-1399. PubMed ID: 36120843
[TBL] [Abstract][Full Text] [Related]
5. Clinical and radiomics integrated nomogram for preoperative prediction of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer.
Hu L; Jin P; Xu W; Wang C; Huang P
Front Oncol; 2024; 14():1370466. PubMed ID: 38567151
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8
Liao H; Zhang Z; Chen J; Liao M; Xu L; Wu Z; Yuan K; Song B; Zeng Y
Ann Surg Oncol; 2019 Dec; 26(13):4537-4547. PubMed ID: 31520208
[TBL] [Abstract][Full Text] [Related]
8. MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.
Kim YA; Lee HJ; Heo SH; Park HS; Park SY; Bang W; Song IH; Park IA; Gong G
Breast Cancer Res Treat; 2016 Apr; 156(3):597-606. PubMed ID: 27075916
[TBL] [Abstract][Full Text] [Related]
9. Radiomic models based on magnetic resonance imaging predict the spatial distribution of CD8
Jeon SH; Kim SW; Na K; Seo M; Sohn YM; Lim YJ
Front Immunol; 2022; 13():1080048. PubMed ID: 36601118
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
[TBL] [Abstract][Full Text] [Related]
11. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
[TBL] [Abstract][Full Text] [Related]
12. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Level of Tumor-Infiltrating Lymphocytes in Patients With Breast Cancer: Usefulness of Mammographic Radiomics Features.
Yu H; Meng X; Chen H; Liu J; Gao W; Du L; Chen Y; Wang Y; Liu X; Liu B; Fan J; Ma G
Front Oncol; 2021; 11():628577. PubMed ID: 33777776
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI.
Xu N; Zhou J; He X; Ye S; Miao H; Liu H; Chen Z; Zhao Y; Pan Z; Wang M
Clin Breast Cancer; 2021 Oct; 21(5):440-449.e1. PubMed ID: 33795199
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes and CD8
Vihervuori H; Autere TA; Repo H; Kurki S; Kallio L; Lintunen MM; Talvinen K; Kronqvist P
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3105-3114. PubMed ID: 31562550
[TBL] [Abstract][Full Text] [Related]
16. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
[TBL] [Abstract][Full Text] [Related]
17. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.
Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y
Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336
[TBL] [Abstract][Full Text] [Related]
18. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C
Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356
[TBL] [Abstract][Full Text] [Related]
19. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
Wang K; Shen T; Siegal GP; Wei S
Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of TILs as a biomarker in triple-negative breast cancer: what is the role of TILs in TME of TNBC?
Zhou Y; Tian Q; Wang BY; Yang J; Zhao SD; Yang J
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2885-2897. PubMed ID: 33877653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
